• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 23, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Media registration open for TCT 2017

Bioengineer by Bioengineer
July 17, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WHAT:

Media registration is open online for TCT 2017 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine, attracting nearly 12,000 attendees from 90 countries all over the world.

For the first time, TCT will be held in Denver, Colorado. Denver is a vibrant, active city at the base of the Colorado Rocky Mountains known for its stunning natural beauty, a thriving cultural scene, and award-winning dining.

Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field. TCT 2017 will also highlight state-of-the-art techniques and hands-on training, as well as high-definition live case transmissions.

To learn more about the conference, please visit http://www.crf.org/tct.

WHEN:

October 29 – November 2, 2017
Agenda Highlights: http://www.crf.org/tct/agenda/tct-2017-agenda

WHERE:

Colorado Convention Center
Denver, CO

WHY:

Heart disease remains the leading cause of death worldwide. Every year, the discoveries made through hundreds of studies and late breaking trials presented at TCT lead to advancements in new medicines and devices that ultimately lead to improved care for patients with heart disease.

HOW TO REGISTER:

Media may apply for registration by visiting:
http://www.crf.org/tct/press/press-registration-form

Details on required press credentials can be found at: http://www.crf.org/tct/press/press-credentials-and-guidelines

###

About CRF and TCT

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world's premier educational meeting specializing in interventional cardiovascular medicine. Now in its 29th year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.

For more information, visit http://www.crf.org and http://www.tctconference.com.

Media Contact

Judy Romero
[email protected]
@CRFHeart

http://www.crf.org

http://www.crf.org/crf/news-and-events/news/news/2227-media-registration-open-for-tct-2017

Share12Tweet8Share2ShareShareShare2

Related Posts

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

August 23, 2026

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

August 23, 2026

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

August 22, 2026

Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

    29 shares
    Share 12 Tweet 7
  • ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

    29 shares
    Share 12 Tweet 7
  • KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

    29 shares
    Share 12 Tweet 7
  • Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.